NCT00531284: Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma |
|
|
| Completed | 1b/2 | 184 | US | Carfilzomib, Kyprolis, Dexamethasone | Amgen | Ovarian Cancer, Renal Cancer, Non-small Cell Lung Cancer, Small Cell Lung Cancer, Solid Tumors, Multiple Myeloma, Lymphoma | 10/14 | 05/17 | | |